Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

AMGLIDIA 0.6 mg/mL, oral suspension with 1 mL oral syringe

Active Ingredient:
glibenclamide
Company:  
AMRING SARL See contact details
ATC code: 
A10BB01
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Amglidia Prescriber Guide

{healthcare_pro_orange} For Healthcare Professionals

Prescribing Information for HCP

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

AMRING SARL
Company image
Address
216 Boulevard, Saint-Germain, 75007 Paris
Telephone
+44 (0) 118 207 9160
Fax
+44 (0) 118 207 9161
Medical Information Direct Line
+44 (0) 800 121 8924
Medical Information e-mail
[email protected]
Medical Information Fax
+44 (0) 44 1748 828801
Stock Availability
[email protected]